Susan Hubl concentrates her practice on U.S. and foreign patent prosecution for companies and institutions in the life science fields of molecular biology tools and methods, personalized medicine and molecular diagnostics, microbiome related technologies, biologics including RNAi and antibodies and cancer therapeutics. Her practice includes providing support for intellectual property counseling, due diligence and litigation where she has done work in the fields of biofuels, therapeutic antibodies, vaccines, PCR reagents, transgenic animals, fertility therapeutics, medical devices and microarrays. Her clients include biotechnology companies, startups, venture capital firms and academic institutions.
Susan has worked as a patent agent and legal technical analyst since 1997. While a graduate student at UC Berkeley, she performed a structure-function mutational analysis of yeast heat shock transcription factor (HSF) in the laboratory of Dr. Hilary Nelson. Before graduate school she worked as a research associate at The Gladstone Institute of Cardiovascular Disease in the laboratory of Dr. Steve Young studying lipoprotein mutations and their role in cardiovascular disease. She was an author on 11 scientific papers in peer reviewed journals.